Surveillance of results of long-term prophylactic treatment of von Willebrand disease with Wilate.
Phase of Trial: Phase IV
Latest Information Update: 02 Jan 2013
At a glance
- Drugs Albumin human/von Willebrand factor (Primary)
- Indications Von Willebrand disease
- Focus Therapeutic Use
- Acronyms WILCOME
- Sponsors Octapharma
- 01 Jan 2013 Status changed from recruiting to completed as reported by ISRCTN: Current Controlled Trials record.
- 17 Sep 2008 New trial record.